New non-small cell lung cancer therapy data have been reported by scientists at University of Verona, Department of Pathology

New research, 'Mixed adenocarcinomas of the lung: place in new proposals in classification, mandatory for target therapy,' is the subject of a report. According to a study from Italy, "Lung cancer is one of the most frequent and lethal malignant neoplasms, but knowledge regarding the molecular basis of its pathogenesis is far from complete due to the striking diversity of different forms. The current lung cancer classification (World Health Organization 2004) can efficiently distinguish clinically relevant major subtypes (small cell and non-small cell carcinomas), but its results are partly inadequate when facing prognostic and therapeutic decisions for non-small cell carcinomas,...

Want to see the full article?

• Purchase this article for only $3.00